What Has Been The Evolution of the Pharmaceutical Contract Packaging Market in Recent Years?
The pharmaceutical contract packaging market has seen considerable growth due to a variety of factors.
• In the past few years, the pharmaceutical contract packaging market has seen robust growth. The market is set to expand from $31.67 billion in 2024 to $34.44 billion in 2025, marking a compound annual growth rate (CAGR) of 8.7%. This historical growth momentum is a result of various factors including stricter packaging regulations, the need to expedite time-to-market, a surge in demand for specialized packaging solutions, the globalization of pharmaceutical supply chains, as well as cost efficiency and operational flexibility stemming from the scalability of production.
What Is the Forecasted Market Size and Growth Rate for The Pharmaceutical Contract Packaging Market By 2029?
The Pharmaceutical Contract Packaging market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of the pharmaceutical contract packaging is projected to witness robust expansion in the coming years, escalating to $48.13 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%.
The surge during the projected period can be credited to factors such as heightened emphasis on green packaging, the necessity for on-demand packing services, emerging trends in customization and personalization, demand for child-proof packaging, and vital investments in packaging framework. Key tendencies anticipated during this forecast period encompass serialization and traceability compliance, progressive developments in packaging machinery, specialization in cold-chain packaging, patient compliant adherence packaging, personalized medicinal packaging, and substantial investments in digital transformation and Industry 4.0.
What Factors Are Driving Growth In The Pharmaceutical Contract Packaging Market?
The pharmaceutical contract packaging market is anticipated to grow in response to the increasing elderly population. People who are 65 years old and above are considered as the elderly population. This demographic shift is prompting manufacturers to come up with packing solutions that are both child-resistant and easy for the elderly to open, although this might lead to higher costs and sustainability issues. For instance, the World Health Organization, a health agency based in Switzerland, reported in October 2024 that the global population of people over 60 years old is projected to rise significantly from 1 billion in 2020 to 1.4 billion by 2030 and further to 2.1 billion by 2050. The number of people aged 80 years and above is also expected to triple, amounting to 426 million by 2050. Consequently, the surge in the elderly population is fuelling the growth of the pharmaceutical contract packaging market.
What Are The Main Segments Of The Global Pharmaceutical Contract Packaging Market?
The pharmaceutical contract packaging market covered in this report is segmented –
1) By Product: Primary Packaging, Secondary Packaging, Tertiary Packaging
2) By Material: Paper And Paperboard, Plastics And Polymers, Aluminum Foil, Glass, Other Materials
3) By Industry: Small Molecule, Biopharmaceutical, Vaccine
Subsegments:
1) By Primary Packaging: Blister Packs, Bottles, Vials, Ampoules, Pre-Filled Syringes
2) By Secondary Packaging: Cartons, Labels, Inserts, Shrink Sleeves
3) By Tertiary Packaging: Shipping Containers, Pallets, Bulk Packaging Solutions
Pre-Book The Pharmaceutical Contract Packaging Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Pharmaceutical Contract Packaging Market?
A notable trend gaining traction in the pharmaceutical contract packaging market is technological innovation. Key players in this sector are focusing on the introduction of groundbreaking technological developments to augment their market share. Gerresheimer AG, a Germany-based drug delivery systems firm, and Stevanato Group, an Italy-based firm specializing in drug containment, drug delivery, and diagnostic solutions highlighted this trend when they debuted EZ-fill Smart in November 2022. This technology facilitates seamless integration with standard fill & finish operations and can handle small to large batch production. The EZ-fill Smart is designed to enhance the quality of drug packaging, decrease the total cost of ownership (TCO), and reduce customer lead times. It also introduces an environmentally friendly sterilization method, and utilizes biopolymers and recycled plastic.
Who Are the Key Players In The Pharmaceutical Contract Packaging Market?
Major companies operating in the pharmaceutical contract packaging market include:
• Nipro Corporation
• Daito Pharmaceutical Co Ltd.
• Pfizer CentreOne
• Catalent Inc.
• WestRock Company
• BALL CORPORATION
• Berlin Packaging
• CCL Industries Inc.
• Co-Pak Packaging Corporation
• Signode India Limited
• Ropack Pharma Solutions
• Reelvision Print Limited
• PCI Pharma Services
• Multi-Pack Solutions LLC
• Unicep Packaging Inc
• Reed-Lane Inc.
• Aphena Pharma Solutions Holdings Inc.
• Southwest Packaging and Supply Corporation
• AbbVie Inc.
• Almac Group Limited
• AmeriPac Inc
• Assemblies Unlimited Inc.
• CentralPharma
• DaklaPack Filling & Packaging
• DelobrisPharmaceuticals Limited
• Elitefill Inc.
• Finishing Services Inc.
• Jones Packaging Inc.
• LABO S.R.L.
• MJS Packaging Inc.
• MPH Co-Packing LLC
• Nelipak B.V.
• Pharma Packaging Solutions LLC
• Sepha Limited
• SternMaid GmbH
What Is The Most Dominant Region In The Pharmaceutical Contract Packaging Market?
North America was the largest region in the pharmaceutical contract packaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the pharmaceutical contract packaging market report during the forecast period. The regions covered in the pharmaceutical contract packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
